Human germline mutation in the factor IX gene

Mutation Research - DNA Repair

Volumn 487, Issue 1-2, 2001, Pages 1-17

  Sommer, S S ^a   Scaringe, W A ^a   Hill, K A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Factor IX gene; Hemophilia; Human germline mutation

Indexed keywords

BLOOD CLOTTING FACTOR 9; NUCLEOTIDE;

ETHNIC DIFFERENCE; GENE MUTATION; GENETIC ANALYSIS; HEMOPHILIA B; HUMAN; MATERNAL AGE; MISSENSE MUTATION; MUTATION RATE; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; SHORT SURVEY;

AGE FACTORS; FACTOR IX; FOUNDER EFFECT; GENE FREQUENCY; GERM-LINE MUTATION; HEMOPHILIA B; HUMANS; MOSAICISM;

EID: 0035501319     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(01)00108-2     Document Type: Short Survey

References (119)

1. Dystrophin the gene and its product
2. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
3. Point mutations in the dystrophin gene
4. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations
5. Recent human germline mutation: Inferences from patients with hemophilia B
6. Homeostasis and bleeding disorders
7. A mutation in the propeptide of factor IX leads to warfarin sensitivity by a novel mechanism
8. Mutation in human populations
9. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986
10. Online Mendelian inheritance in man (OMIM)
11. Plasma thromboplastin component (PTC) deficiency: A new disease resembling hemophilia
12. Christmas disease: A condition previously mistaken for haemophilia
13. X-ray structure of clotting factor IXa: Active site and module structure related to Xase activity and hemophilia B
14. Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy
15. 2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions
16. Coagulation factor IXa: The relaxed conformation of Tyr99 blocks substrate binding
17. Modeling human zymogen factor IX
18. Variants of Vitamin K dependent coagulation factors
19. Molecular pathology of haemophilia B
20. The hemophilias
21. The factor IX gene as a model for analysis of human germline mutations: An update
22. The molecular basis of haemophilia B
23. Missense mutations and evolutionary conservation of amino acids: Evidence that many of the amino acids in factor IX function as spacer elements
24. Determinants of the factor IX mutational spectrum in haemophilia B: An analysis of missense mutations using a multi-domain molecular model of the activated protein
25. Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B
26. Haemophilia B mutations in Sweden: A population-based study of mutational heterogeneity
27. Spontaneous mutation in man
28. Mutations causing hemophilia B: Direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in the human gene
29. Spontaneous mutation in Big Blue transgenic mice: Analysis of age, gender, and tissue type
30. The X chromosome and the rate of deleterious mutations in humans
31. The sequence of the human genome
32. Clinical implications of the p53 tumor-suppressor gene
33. p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer
34. Mutations in the p53 gene are frequent in primary
35. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
36. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
37. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
38. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
39. 1 induces the transversion of G → T in codon 249 of the p53 tumor suppressor gene in human hepatocytes
40. Aberrations of p53 gene in human hepatocellular carcinoma from China
41. Mutagen test
42. The molecular epidemiogy of p53 gene mutations in human breast cancer
43. The pattern of factor IX germline mutation in Asians is similar to that of Caucasians
44. Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and of the ratio of the sex-specific mutation rates in Sweden
45. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample
46. Germline mutations in the factor IX gene: A comparison of the pattern in Caucasians and non-Caucasians
47. Recurrent mutations in the factor IX gene: Founder effect or repeat de novo events
48. UK haemophilia centers. First report on UK database of haemophilia B mutations and pedigrees
49. Molecular epidemiology of factor IX germline mutations in Mexican Hispanics: Pattern of mutation and potential founder effects
50. Germline mutations in Peruvian patients with hemophilia B: Pattern of mutation in AmerIndians is similar to the putative endogenous germline pattern
51. The human factor IX gene as germline mutagen test: Samples from mainland China have the putatively endogenous pattern of mutation
52. Factor IX Mutations in South Africans and African-Americans are compatible with primarily endogenous influences upon recent germune mutations
53. Does cancer kill the individual and save the species?
54. The contribution of exogenous and endogenous mutagens to in vivo mutations
55. The pattern of spontaneous germline mutation: Relative rates of mutation at or near CpG dinucleotides in the factor IX gene
56. Carcinogens preferentially bind at methylated CpG in the p53 mutational hotspots
57. Why does the human factor IX gene have a G+C content of 40%?
58. Patterns of nucleotide substitution in pseudogenes and functional genes
59. Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications
60. Neighboring base effects on substitution rates in pseudogenes
61. Wide variations in neighbor-dependent substitution rates
62. Rates of nucleotide substitution and mammalian nuclear gene evolution. Approximate- and maximum-likelihood methods lead to different conclusions
63. Single base-pair substitutions in pathology and evolution: Two sides to the same coin
64. Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG
65. The rates of G:C → T:A and G:C → C:G transversions at CpG dinucleotides in the human factor IX gene
66. Achondroplasia is defined by recurrent G380R mutations of FGFR3
67. A mutation in the 3′ untranslated region of the factor IX gene in four families with hemophilia B
68. Microdeletions in the factor IX gene: Three recurrences associated with a quasipalindromic sequence
69. Deletions with inversions: Report of a mutation and review of the literature
70. The rates and patterns of deletions in the human factor IX gene
71. A postulated mechanism for deletions with inversions
72. Are some apparently simple deletions actually two concerted deletions that result from interacting RY(i) hairpin loops?
73. Nine independent F9 mutations in the Mexican hemophilia B population: Nonrandom recurrences of point mutation events in the human germline
74. Novel hotspot detector software reveals a non-CpG hotspot of germline mutation in the factor IX gene (F9) in Latin Americans
75. Evidence that descendants of three founders comprise about 25% of hemophilia B in the US
76. Factor IX gene analysis in 70 unrelated patients with haemophilia B: Description of 13 new mutations
77. Zur verebung des zwergwuchses
78. The mutation rate of the gene for hemophilia, and its segregation ratios in males and females
79. Mutation: Spontaneous mutation in germ cells
80. High male:female ratio of germline mutations: An alternative explanation for postulated gestational lethality in males in X-linked dominant disorders
81. RFLP analysis in families with sporadic hemophilia A. Estimate of the mutation ratio in male and female gametes
82. Carrier detection of haemophilia A using DNA markers in families with an isolated affected male
83. Sex ratio of the mutation frequencies in haemophilia A: Estimation and meta-analysis
84. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: Family studies indicate a mutation type-dependent sex ratio of mutation frequencies
85. Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells
86. Factor VIII gene inversions in severe hemophilia A: Results of an international consortium study
87. Germline origins of mutation in families with hemophilia B: The sex ratio varies with the type of mutation
88. Germline origins in the human F9 gene: Frequent G:C → A:T mosaicism and increased mutations with advanced maternal age
89. Germline origins of de novo mutations in hemophilia B families
90. Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: A European study
91. On the origin of deletions and point mutations in Duchenne muscular dystrophy: Most deletions arise in oogenesis and most point mutations result from events in spermatogenesis
92. Estimation of the male and female mutation rates in Duchenne muscular dystrophy
93. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome
94. Exclusive paternal origin of new mutations in Apert syndrome
95. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin
96. Spontaneous mutation and parental age in humans
97. The origins, patterns and implications of human spontaneous mutation
98. Parental origin of factor IX gene mutations, and their distribution in the gene
99. Germinal mosaicism increases the recurrence risk for new Duchenne muscular dystrophy mutations
100. Mosaicism and sporadic haemophilia: Implication for carrier determination
101. Germline and gonosomal mosaicism in the ATR-X syndrome
102. Maternal gonadal mosaicism causing ornithine transcarbamylase deficiency
103. Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene
104. First description of germline mosaicism in familial hypertrophic cardiomyopathy
105. A somatic mosaic for haemophilia A detected at the DNA level
106. Somatic mosaicism in a patient with bilateral retinoblastoma
107. Clinical and molecular spectrum of somatic mosaicism in androgen insensitivity syndrome
108. Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: Further evidence for a contiguous gene syndrome in 17q1 1.2
109. Somatic mosaicism and compound heterozygosity in female hemophilia B
110. The conradi-Hunermann-happle syndrome (CDPX2) and emopamil binding protein: Novel mutations, and somatic and gonadal mosaicism
111. Somatic mosaicism in von Hippel-Lindau Disease
112. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a
113. High rate of mosaicism in tuberous sclerosis complex
114. Somatic mosaicism in hemophilia A: A fairly common event
115. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
116. A catalogue of splice junction sequences
117. RNA splice junctions of different classes of eukaryotes; sequence statistics and functional implications in gene expression
118. Reported in vivo splice-site mutations in the factor IX gene: Severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations